A synthetic gene is a sequence somebody writes and a supplier builds from oligonucleotides, assembles, clones and sequence-verifies, and it has largely replaced cloning from a template for anything that is not already in a freezer nearby. What decides the price and the wait is not the biology but four specifications, and a request that states all four comes back quoted rather than queried.
What a specification has to carry
Four things decide a quote. The sequence itself, written unambiguously and in the reading frame you intend, with the codon usage either left alone or recoded for a stated host. The delivery vector, either the supplier's standard cloning plasmid or an expression vector you name, which is where most delays come from. The scale and format, plasmid DNA at a stated amount or a linear fragment. And the verification, since full sequence confirmation of the insert and the junctions is what you are paying for beyond the synthesis.
Where synthesis beats cloning from a template
Synthesis wins whenever the template is inconvenient: a sequence from a database rather than a sample, a variant that would need several rounds of mutagenesis, a codon set recoded for another host, a construct that needs sites removed or added, or anything where the cloning would take a month of somebody's time. Cloning still wins when the template is in the building, the construct is simple and the budget is a student's. The crossover has moved steadily toward synthesis as price per base has fallen.
What makes a sequence hard to build
Price and lead time rise with features the chemistry dislikes: long repeats and inverted repeats, homopolymer runs, very high or very low GC content, secondary structure in the assembly junctions, and anything toxic to the propagation host, which shows up as a construct that cannot be grown rather than one that cannot be made. Most suppliers screen a submitted sequence and come back with a redesign or a surcharge, and a synonymous change agreed early is cheaper than a failed build reported late.
What the supplier guarantees
Read the guarantee rather than the marketing. The usual commitment is a clone whose insert matches the submitted sequence exactly, evidenced by a trace or a read set supplied with the tube, and a stated amount of plasmid at a stated purity. What is not guaranteed is that the gene expresses, that the protein folds, or that a sequence unstable in the host will stay intact through your own propagation, which is why the first job on arrival is a prep and a restriction check of your own.
synthetic grna, and what a synthetic guide specifies
A chemically synthesised guide arrives as a single molecule ready to complex with the nuclease, which is what ribonucleoprotein delivery needs, and its specification is short but unforgiving: the twenty nucleotide spacer written five prime to three prime without the PAM, the scaffold, the modification pattern that protects the ends from exonucleases in a cell, and the purification grade. Synthesis is the fast route for a handful of guides; a plasmid or a library is cheaper once the count rises, and the delivery method decides which.
A piggybac transposase plasmid and the pair it belongs to
A piggybac transposase plasmid supplies the enzyme separately from the donor carrying the cargo, and supplying it transiently rather than integrating it is what stops continued mobilisation after the insertion. The ratio of transposase to donor is titrated, because too much lowers integration rather than raising it, and messenger RNA or protein delivery is the cleaner alternative.
custom oligonucleotide synthesis and what an order states
custom oligonucleotide synthesis is specified by sequence, scale, purification, modification and quality control, and the same sequence at two purities behaves differently in a sensitive assay. Full length yield falls with length, so a long oligonucleotide is limited by purification rather than by scale, and mass confirmation is worth specifying for anything modified.
A cmv primer and what it is for
A cmv primer in a catalog is usually a sequencing or amplification primer against the common viral promoter used in expression vectors, which is why it appears in cloning rather than virology work. Because the promoter is in thousands of constructs, the primer is a standard reagent, and its binding site's distance from the insert decides whether a read covers the junction.
vsv-g and the envelope that decides tropism
The VSV-G envelope is what gives a lentiviral particle its broad tropism and its stability to concentration, and it is also what sets the biosafety consideration, because a broadly tropic particle infects the operator's cells as readily as the target's. Alternatives with narrower tropism exist and lower titre, and the envelope used belongs in a risk assessment.
A lentiviral packaging mix and what it replaces
A lentiviral packaging mix supplies the packaging and envelope plasmids at a set ratio so only the transfer vector is added, which removes the commonest source of variation between preparations. What it hides is which generation of system is being used, and that is what the biosafety assessment rests on, so the composition belongs in the record rather than the product name.
Questions people ask about synthetic genes
Recode the codons or keep the native sequence?
Recode for expression in a host distant from the source organism, keep the native sequence when the study is about the sequence itself, regulatory elements or rare codon effects.
Fragment or plasmid?
A linear fragment is cheaper and suits assembly into your own vector; a sequence-verified plasmid is what most projects should buy, because the verification is the expensive part to repeat.
What arrives with the order?
Plasmid DNA or a fragment at a stated amount, with the sequence evidence for the insert and its junctions. Check it against the submitted file before use.